Choroidal melanoma therapy offers promising treatment option

Source: Healio, April 2019

HILADELPHIA — A choroidal melanoma therapy has been shown to reduce tumor thickness and preserve best corrected visual acuity in patients participating in a phase 1b/2 study, according to a speaker here.

AU-011 (Aura Biosciences) has been administered to 30 patients with choroidal melanoma, demonstrating 87% tumor control in subjects with a single cycle treatment up to 6 months, Carol L. Shields, MD, said at the Wills Eye Conference.

“This is a safe treatment for both single and multiple administrations. Inflammation is manageable, and we have seen reduction in tumor thickness. One case actually had fine needle aspiration biopsy at 8 months, and there was complete tumor necrosis. No melanoma was left in the needle biopsy,” Shields said.

read the original full article

2019 Events

Calculate your risk of getting melanoma Sunscreen calculator
Map of body for recording areas of skin causing you concern on your body Target Therapy Finder